Fig. 1From: Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern EuropeCorrelation between total gross domestic product (GDP) and total public expenditures on the reimbursement of analysed drugs in 2014, 2015, and 2016, as well as an average valueBack to article page